LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
64.09
-0.11 (-0.17%)
Jan 27, 2026, 4:00 PM EST - Market closed
LivaNova Employees
LivaNova had 2,900 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$465,159
Profits / Employee
-$74,995
Market Cap
3.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2,900 | 0 | - |
| Dec 31, 2023 | 2,900 | 0 | - |
| Dec 31, 2022 | 2,900 | -100 | -3.33% |
| Dec 31, 2021 | 3,000 | -1,000 | -25.00% |
| Dec 31, 2020 | 4,000 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 24, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| QuidelOrtho | 6,600 |
| UFP Technologies | 4,146 |
| Haemonetics | 3,023 |
| iRhythm Holdings | 2,000 |
| Artivion | 1,600 |
| Inspire Medical Systems | 1,246 |
| Establishment Labs Holdings | 1,023 |
LIVN News
- 7 days ago - LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - Business Wire
- 13 days ago - LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - LivaNova to Present at J.P. Morgan Healthcare Conference in January - Business Wire
- 7 weeks ago - LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - Business Wire
- 2 months ago - LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - Business Wire
- 2 months ago - LivaNova to Present at Piper Sandler Healthcare Conference in December - Business Wire
- 2 months ago - LivaNova's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services - Business Wire
- 2 months ago - LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day - Business Wire